SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is gaining significant traction as it nears 4/20, with the community rallying around its branding as a decentralized, culture-focused alternative to traditional cannabis stocks. Supporters are actively discussing the coin's growth, potential legislative catalysts, and its role as a digital gathering point for enthusiasts, while emphasizing a long-term, community-driven approach.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently facing intense market volatility following social media speculation that suggests AI startup Anthropic is disrupting its core business, triggering a significant sell-off despite company fundamentals remaining a primary focus for long-term investors. The community is sharply divided, with many labeling the negative commentary as market manipulation and a buying opportunity, while others express concerns over the stock's high valuation and potential long-term competition in the evolving enterprise AI landscape.

Litecoin is a decentralized, peer-to-peer digital currency designed to enable instant, near-zero cost payments to individuals and merchants worldwide. As an open-source global payment network that functions independently of central banks or intermediaries, its main value proposition lies in providing a scarce digital asset with a fixed maximum supply of 84 million tokens.  The network operates using a Proof of Work mechanism where computers solve complex puzzles to confirm transactions and secure the blockchain. It is distinguished by a block generation time of 2.5 minutes, which allows for faster transaction confirmations and a higher total throughput than earlier protocols. Key technical features include the Scrypt hashing algorithm, which promotes wider network participation, and MimbleWimble Extension Blocks, which improve user privacy by allowing transaction details to be hidden.  The LTC token is used for settling global payments, executing microtransactions through smaller units called litoshis, and diversifying digital portfolios with a highly liquid asset. New tokens are issued to miners as rewards for verifying blocks, though these rewards undergo a halving event approximately every four years to strictly control inflation. This process ensures the ledger maintains immutability, meaning records cannot be changed once they are saved to the global network.  Created by former Google engineer Charlie Lee, the project is supported by the Litecoin Foundation, a non-profit organization dedicated to ecosystem adoption. Unlike many venture-backed projects, it is maintained by a decentralized community of independent developers and a global network of miners. The project has seen recent institutional adoption, with entities like Lite Strategy and Luxxfolio Holdings adding significant amounts of LTC to their corporate treasuries as of late 2025.

Litecoin

Litecoin is currently driving intense debate as investors weigh its long-term payment utility and accumulation by institutions against its persistent price underperformance compared to other major cryptocurrencies. While some traders point to bullish technical setups and potential network upgrades as signals of an impending breakout, skeptics highlight ongoing lack of institutional inflow and stagnant chart patterns as evidence of the asset's continued decline.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow is facing intense downward pressure as investors rotate out of software stocks, driven by widespread anxiety that AI agents could disrupt seat-based pricing models. While the community remains deeply divided, bullish traders are pointing to the company's strong fundamentals and insider buying as signs of a potential long-term bargain, while bears argue that technical breakdowns and sector-wide sentiment suggest further downside.

iShares Trust - iShares Expanded Tech-Software Sector ETF

iShares Expanded Tech-Software Sector ETF

The iShares Expanded Tech-Software Sector ETF (IGV) is currently the focal point of a intense debate regarding whether enterprise software companies are fundamentally threatened by AI-driven disruption or if the recent sector-wide sell-off presents a generational value opportunity. The community is actively tracking institutional volume and short interest data, with bulls arguing that software earnings remain resilient and that current price levels are heavily disconnected from long-term enterprise demand.

Back in 2011, long before “crypto Twitter”, NFTs, or VC-backed chains existed, users of the BitcoinTalk forum came up with a new currency - not to launch a network, but to make fun of btc.... and so: The first memecoin/memecurrency was born.  On May 23, 2011, a Something Awful poster cracked, “Has anyone called them buttcoins yet?”. It was sophomoric and perfect. Within weeks the gag metastasized into Buttcoin.org, a parody blog that described a “peer to peer butt” economy while cataloging mining fiascos, exchange blowups, and MLM-adjacent “innovations”.

Buttcoin

Buttcoin is capturing significant community attention as a legacy meme that predates modern crypto trends, with supporters touting its 2011 origins and satirical nature as a unique long-term play. Discussion is currently focused on its potential for generational wealth, with some investors drawing parallels to the early stages of major market-moving assets.

Avis Budget Group, Inc. engages in the provision of vehicle sharing and rental services. It operates through the Americas and International segments. The Americas segment includes vehicle rental and car sharing operations in North America, South America, Central America, and the Caribbean. The International segment is involved in vehicle rental and car sharing operations in Europe, the Middle East, Africa, Asia, and Australasia. The company was founded in 1946 and is headquartered in Parsippany, NJ.

Avis Budget Group Inc

Avis Budget Group is experiencing significant volatility and intense speculation as market participants debate the stock's potential for a massive short squeeze, citing high short interest and institutional ownership. While bulls are focused on repeating historical price spikes, bears are highlighting concerning fundamentals, including heavy debt, ongoing equity offerings, and skepticism regarding the company's long-term profitability.

VanEck ETF Trust - VanEck Semiconductor ETF

VanEck Semiconductor ETF

The VanEck Semiconductor ETF (SMH) is facing intense community debate as it hits new all-time highs, with some investors betting on continued AI infrastructure momentum while others warn of a parabolic bubble fueled by unsustainable capex and financing feedback loops. Market participants are closely watching the SMH/IGV ratio as an indicator of broader institutional rotation, with discussions centering on whether current semiconductor strength represents a structural cycle or an overextended speculative peak.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune Group is seeing heightened investor activity as the market reacts to the FDA's acceptance of its BLA resubmission, which has set a PDUFA date for April 2026. The community is actively debating the likelihood of approval versus the risk of another complete response letter, with many traders focused on the stock's significant short interest and the potential for a volatility-driven squeeze leading up to the final decision.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is seeing significant volatility following a preliminary revenue guidance announcement and updates on factory automation that have polarized the investor community. While some traders view the recent price action as a technical bounce and a prime opportunity for a short squeeze, others are expressing heavy skepticism due to pending class-action lawsuits and lingering concerns regarding the company's ability to scale manufacturing and regain shareholder trust.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Defense, Biotech, and Aerospace Stories Dominate

Markets are opening Thursday with a mix of defense innovation, biotech progress, aerospace supply chain momentum, and turnaround earnings, highlighting how technology and strategic manufacturing continue to drive investor attention across several sectors. From next-generation biomaterials to counter-drone systems and aerospace electronics, the latest corporate developments suggest continued capital flow toward industries tied to national security, healthcare innovation, and advanced manufacturing. $KBLB, $IBO, $GXAI, $MOBX, $BTAI, $ALTO

<ul class="summary-bullets"><li>Under the revised agreement, the combined public company will issue around 169.6 million ordinary shares.</li><li>The combined public company will also issue 128,000 shares to DSS, its parent company.</li><li>This follows a June 2025 agreement to combine Dr Ashleys’ manufacturing with Impact BioMedical’s portfolio of more than 90 medical patents.</li></ul>Shares of Impact BioMedical (IBO) soared over 65% in pre-market trading on Thursday, after the company announced amendments to agreements tied to its planned merger with Dr Ashleys.If the pre-market level holds after the opening bell, <a href="https://stocktwits.com/symbol/IBO">IBO stock</a> would hit its highest since Sept. 12, 2025.<h2 class="st-heading-2">PubCo To Issue 169.6 Million Shares</h2>Under the revised agreement, the combined public company, referred to as PubCo, will issue 169,560,000 ordinary shares, which represent about 94.2% of PubCo’s outstanding shares at the closing of the business combination. These shares are called the Company Share Consideration.PubCo will issue 22,000 shares to Impact’s CEO, Frank D. Heuszel, and up to 128,000 shares to DSS in two batches. DSS is the parent company of Impact BioMedical. These shares will be&nbsp;deducted from the PubCo’s Company Share Consideration.Additionally, the deadline to complete the merger was extended from March 31, 2026, to July 1, 2026, while shareholders who support the transaction currently control about 88.9% of Impact BioMedical’s shares.<h2 class="st-heading-2">Merger To Open Up Manufacturing Access For Impact</h2>In June 2025, Impact BioMedical and Dr Ashleys signed a definitive merger agreement with Dr Ashleys. The transaction will create a new holding company that will own both Dr Ashleys and Impact BioMedical as subsidiaries. The combined company will be led by Dr Ashleys’ executive team and a newly appointed board.The merger aims to combine Dr Ashleys’ manufacturing and global market access with Impact BioMedical’s portfolio of more than 90 patents covering treatments for cancer, infectious diseases, respiratory illnesses, and orphan drugs.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>The stock garnered significant retail buzz, with Stocktwits data indicating a 14,200% increase in message volumes over the past 24 hours, while retail sentiment on the platform turned ‘extremely bullish’ from ‘bullish’ a day back.<img src="https://news.stocktwits-cdn.com/ibo_jpg_729ebe600c.webp" alt="ibo.jpg">One user sees a rally if the stock breaks over $0.8. It is currently at $0.69.<stembedurl>https://stocktwits.com/TroubleMaker/message/646636004</stembedurl>Another user sees the stock climbing to the $2.45 - $3 range.<stembedurl>https://stocktwits.com/Flybeast/message/646657749</stembedurl>Year-to-date, the stock has gained around 36%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-btai-stock-surge-in-pre-market-today/cZdQs29RI3E">Why Did BTAI Stock Surge 20% In Pre-Market Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Did IBO Stock Surge 65% In Pre-Market Today?

The company announced amendments to agreements related to its planned merger with Dr. Ashley's, including extending the deadline to complete the merger to July 1, 2026.

IBO Stock Spikes Pre-Market: Retail Traders Pile Into Biotech Penny Stock After Merger Update

Equity

Impact BioMedical, Inc. is a holding company, which engages in the discovery and development of products and treatment options in specialty biopharmaceuticals and consumer healthcare. The firm focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological and immune related diseases. It is also involved in developing open-air defense initiatives, which curb transmission of air-borne infectious diseases, such as tuberculosis and influenza. The company was founded on October 16, 2018 and is headquartered in Houston, TX.

IBO
Impact BioMedical Inc.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest IBO News

IBOImpact BioMedical Inc.